Top

Published in:

01-03-2009 | Review

The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications

Authors: Yasushi Toh, Garth L. Nicolson

Published in: Clinical & Experimental Metastasis | Issue 3/2009

Abstract

MTA (metastasis-associated gene) is a newly discovered family of cancer progression-related genes and their encoded products. MTA1, the first gene found in this family, has been repeatedly reported to be overexpressed along with its protein product MTA1 in a wide range of human cancers. In addition, the expression of MTA1/MTA1 correlates with the clinicopathological properties (malignant properties) of human cancers. MTA proteins are transcriptional co-repressors that function in histone deacetylation and are involved in the NuRD complex, which contains nucleosome remodeling and histone deacetylating molecules. MTA1 expression correlates with tumor formation in the mammary gland. In addition, MTA1 converts breast cancer cells to a more aggressive phenotype by repression of the estrogen receptor (ER) α trans-activation function through deacetylation of the chromatin in the ER-responsive element of ER-responsive genes. Furthermore, MTA1 plays an essential role in c-MYC-mediated cell transformation. Another member of this family, MTA3, is induced by estrogen and represses the expression of the transcriptional repressor Snail, a master regulator of “epithelial to mesenchymal transitions”, resulting in the expression of the cell adhesion molecule E-cadherin and maintenance of a differentiated, normal epithelial phenotype in breast cells. In addition, tumor suppressor p53 protein is deacetylated and inactivated by both MTA1 and MTA2, leading to inhibition of growth arrest and apoptosis. Moreover, a hypoxia-inducible factor-1α (HIF-1α) is also deacetylated and stabilized by MTA1, resulting in angiogenesis. Thus, MTA proteins, especially MTA1, represent a possible set of master co-regulatory molecules involved in the carcinogenesis and progression of various malignant tumors. MTA proteins are proposed to be important new tools for clinical application in cancer diagnosis and treatment.

Toh Y, Pencil SD, Nicolson GL (1994) A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem 269:22958–22963PubMed

Toh Y, Pencil SD, Nicolson GL (1995) Analysis of the complete sequence of the novel metastasis-associated candidate gene, mta1, differentially expressed in mammary adenocarcinoma and breast cancer cell lines. Gene 159:97–104. doi:10.1016/0378-1119(94)00410-T PubMedCrossRef

Nawa A, Nishimori K, Lin P et al (2000) Tumor metastasis-associated human MTA1 gene: its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides. J Cell Biochem 79:202–212. doi:10.1002/1097-4644(20001101)79:2<202::AID-JCB40>3.0.CO;2-LPubMedCrossRef

Toh Y, Oki E, Oda S et al (1997) Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer 74:459–463. doi:10.1002/(SICI)1097-0215(19970822)74:4<459::AID-IJC18>3.0.CO;2-4PubMedCrossRef

Toh Y, Kuwano H, Mori M et al (1999) Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br J Cancer 79:1723–1726. doi:10.1038/sj.bjc.6690274 PubMedCrossRef

Kumar R, Wang RA, Bagheri-Yarmand R (2003) Emerging roles of MTA family members in human cancers. Semin Oncol 30:30–37. doi:10.1053/j.seminoncol.2003.08.005 PubMedCrossRef

Manavathi B, Kumar R (2007) Metastasis tumor antigens, an emerging family of multifaceted master coregulators. J Biol Chem 282:1529–1533. doi:10.1074/jbc.R600029200 PubMedCrossRef

Manavathi B, Singh K, Kumar R (2007) MTA family of coregulators in nuclear receptor biology and pathology. Nucl Recept Signal 5:e010PubMed

Bowen NJ, Fujita N, Kajita M, Wade PA (2004) Mi-2/NuRD: multiple complexes for many purposes. Biochim Biophys Acta 1677:52–57PubMed

10.

Singh RR, Kumar R (2007) MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer. J Mammary Gland Biol Neoplasia 12:115–125. doi:10.1007/s10911-007-9043-7 PubMedCrossRef

11.

Solari F, Bateman A, Ahringer J (1999) The Caenorhabditis elegans genes egl-27 and egr-1 are similar to MTA1, a member of a chromatin regulatory complex, and are redundantly required for embryonic patterning. Development 126:2483–2494PubMed

12.

Moon WS, Chang K, Tarnawski AS (2004) Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: relationship to vascular invasion and estrogen receptor-alpha. Hum Pathol 35:424–429. doi:10.1016/j.humpath.2003.11.007 PubMedCrossRef

13.

Bagheri-Yarmand R, Balasenthil S, Gururaj AE et al (2007) Metastasis-associated protein 1 transgenic mice: a new model of spontaneous B-cell lymphomas. Cancer Res 67:7062–7067. doi:10.1158/0008-5472.CAN-07-0748 PubMedCrossRef

14.

Balasenthil S, Broaddus RR, Kumar R (2006) Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas. Hum Pathol 37:656–661. doi:10.1016/j.humpath.2006.01.024 PubMedCrossRef

15.

Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA (2003) MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113:207–219. doi:10.1016/S0092-8674(03)00234-4 PubMedCrossRef

16.

Kumar R, Wang RA, Mazumdar A et al (2002) A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm. Nature 418:654–657. doi:10.1038/nature00889 PubMedCrossRef

17.

Martin MD, Fischbach K, Osborne CK, Mohsin SK, Allred DC, O’Connell P (2001) Loss of heterozygosity events impeding breast cancer metastasis contains the MTA1 gene. Cancer Res 61:3578–3580PubMed

18.

Martin MD, Hilsenbeck SG, Mohsin SK et al (2006) Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies. Breast Cancer Res Treat 95:7–12. doi:10.1007/s10549-005-9016-8 PubMedCrossRef

19.

Jang KS, Paik SS, Chung H, Oh YH, Kong G (2006) MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers. Cancer Sci 97:374–379. doi:10.1111/j.1349-7006.2006.00186.x PubMedCrossRef

20.

Giannini R, Cavallini A (2005) Expression analysis of a subset of coregulators and three nuclear receptors in human colorectal carcinoma. Anticancer Res 25:4287–4292PubMed

21.

Toh Y, Ohga T, Endo K et al (2004) Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas. Int J Cancer 110:362–367. doi:10.1002/ijc.20154 PubMedCrossRef

22.

Kidd M, Modlin IM, Mane SM, Camp RL, Eick G, Latich I (2006) The role of genetic markers–NAP1L1, MAGE-D2, and MTA1–in defining small-intestinal carcinoid neoplasia. Ann Surg Oncol 13:253–262. doi:10.1245/ASO.2006.12.011 PubMedCrossRef

23.

Modlin IM, Kidd M, Pfragner R, Eick GN, Champaneria MC (2006) The functional characterization of normal and neoplastic human enterochromaffin cells. J Clin Endocrinol Metab 91:2340–2348. doi:10.1210/jc.2006-0110 PubMedCrossRef

24.

Kidd M, Modlin IM, Pfragner R et al (2007) Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1. Cancer 109(12):2420–2431. doi:10.1002/cncr.22725 PubMedCrossRef

25.

Kidd M, Modlin IM, Mane SM et al (2006) Utility of molecular genetic signatures in the delineation of gastric neoplasia. Cancer 106:1480–1488. doi:10.1002/cncr.21758 PubMedCrossRef

26.

Modlin IM, Kidd M, Latich I et al (2006) Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed. Ann Surg 244:52–60. doi:10.1097/01.sla.0000217617.06782.d5 PubMedCrossRef

27.

Iguchi H, Imura G, Toh Y, Ogata Y (2000) Expression of MTA1, a metastasis-associated gene with histone deacetylase activity in pancreatic cancer. Int J Oncol 16:1211–1214PubMed

28.

Miyake K, Yoshizumi T, Imura S et al (2008) Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas 36:e1–e9. doi:10.1097/MPA.0b013e3181675010 PubMedCrossRef

29.

Hamatsu T, Rikimaru T, Yamashita Y et al (2003) The role of MTA1 gene expression in human hepatocellular carcinoma. Oncol Rep 10:599–604PubMed

30.

Ryu SH, Chung YH, Lee H et al (2008) Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma. Hepatology 47:929–936. doi:10.1002/hep.22124 PubMedCrossRef

31.

Sasaki H, Moriyama S, Nakashima Y et al (2002) Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer 35:149–154. doi:10.1016/S0169-5002(01)00329-4 PubMedCrossRef

32.

Yi S, Guangqi H, Guoli H (2003) The association of the expression of MTA1, nm23H1 with the invasion, metastasis of ovarian carcinoma. Chin Med Sci J 18:87–92PubMed

33.

Sasaki H, Yukiue H, Kobayashi Y et al (2001) Expression of the MTA1 mRNA in thymoma patients. Cancer Lett 174:159–163. doi:10.1016/S0304-3835(01)00704-2 PubMedCrossRef

34.

Dannenmann C, Shabani N, Friese K, Jeschke U, Mylonas I, Bruning A (2008) The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO. Cancer Biol Ther 7:1460–1467PubMed

35.

Hofer MD, Kuefer R, Varambally S et al (2004) The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res 64:825–829. doi:10.1158/0008-5472.CAN-03-2755 PubMedCrossRef

36.

Hofer MD, Tapia C, Browne TJ, Mirlacher M, Sauter G, Rubin MA (2006) Comprehensive analysis of the expression of the metastasis-associated gene 1 in human neoplastic tissue. Arch Pathol Lab Med 130:989–996PubMed

37.

Roepman P, de Jager A, Groot Koerkamp MJ, Kummer JA, Slootweg PJ, Holstege FC (2006) Maintenance of head and neck tumor gene expression profiles upon lymph node metastasis. Cancer Res 66:11110–11114. doi:10.1158/0008-5472.CAN-06-3161 PubMedCrossRef

38.

Kawasaki G, Yanamoto S, Yoshitomi I, Yamada S, Mizuno A (2008) Overexpression of metastasis-associated MTA1 in oral squamous cell carcinomas: correlation with metastasis and invasion. Int J Oral Maxillofac Surg 37:1039–1046. doi:10.1016/j.ijom.2008.05.020 PubMedCrossRef

39.

Mazumdar A, Wang RA, Mishra SK et al (2001) Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol 3:30–37. doi:10.1038/35050532 PubMedCrossRef

40.

Bagheri-Yarmand R, Talukder AH, Wang RA, Vadlamudi RK, Kumar R (2004) Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis. Development 131:3469–3479. doi:10.1242/dev.01213 PubMedCrossRef

41.

Balasenthil S, Gururaj AE, Talukder AH et al (2007) Identification of Pax5 as a target of MTA1 in B-cell lymphomas. Cancer Res 67:7132–7138. doi:10.1158/0008-5472.CAN-07-0750 PubMedCrossRef

42.

Mahoney MG, Simpson A, Jost M et al (2002) Metastasis-associated protein (MTA)1 enhances migration, invasion, and anchorage-independent survival of immortalized human keratinocytes. Oncogene 21:2161–2170. doi:10.1038/sj.onc.1205277 PubMedCrossRef

43.

Qian H, Lu N, Xue L et al (2005) Reduced MTA1 expression by RNAi inhibits in vitro invasion and migration of esophageal squamous cell carcinoma cell line. Clin Exp Metastasis 22:653–662. doi:10.1007/s10585-006-9005-2 PubMedCrossRef

44.

Hofer MD, Menke A, Genze F, Gierschik P, Giehl K (2004) Expression of MTA1 promotes motility and invasiveness of PANC-1 pancreatic carcinoma cells. Br J Cancer 90:455–462. doi:10.1038/sj.bjc.6601535 PubMedCrossRef

45.

Tong JK, Hassig CA, Schnitzler GR, Kingston RE, Schreiber SL (1998) Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 395:917–921. doi:10.1038/27699 PubMedCrossRef

46.

Xue Y, Wong J, Moreno GT, Young MK, Cote J, Wang W (1998) NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 2:851–861. doi:10.1016/S1097-2765(00)80299-3 PubMedCrossRef

47.

Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D (1999) Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 13:1924–1935. doi:10.1101/gad.13.15.1924 PubMedCrossRef

48.

Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F, Wolffe AP (1999) Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat Genet 23:62–66PubMed

49.

Toh Y, Kuninaka S, Endo K et al (2000) Molecular analysis of a candidate metastasis-associated gene, MTA1: possible interaction with histone deacetylase 1. J Exp Clin Cancer Res 19:105–111PubMed

50.

Fearon ER (2003) Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer. Cancer Cell 3:307–310. doi:10.1016/S1535-6108(03)00087-4 PubMedCrossRef

51.

Tang CK, Perez C, Grunt T, Waibel C, Cho C, Lupu R (1996) Involvement of heregulin-beta2 in the acquisition of the hormone-independent phenotype of breast cancer cells. Cancer Res 56:3350–3358PubMed

52.

Cui Y, Niu A, Pestell R et al (2006) Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells. Mol Endocrinol 20:2020–2235. doi:10.1210/me.2005-0063 PubMedCrossRef

53.

Khaleque MA, Bharti A, Gong J et al (2008) Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1. Oncogene 27:1886–1893. doi:10.1038/sj.onc.1210834 PubMedCrossRef

54.

Talukder AH, Mishra SK, Mandal M et al (2003) MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions. J Biol Chem 278:11676–11685. doi:10.1074/jbc.M209570200 PubMedCrossRef

55.

Mishra SK, Mazumdar A, Vadlamudi RK et al (2003) MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions. J Biol Chem 278:19209–19219. doi:10.1074/jbc.M301968200 PubMedCrossRef

56.

Talukder AH, Gururaj A, Mishra SK, Vadlamudi RK, Kumar R (2004) Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator. Mol Cell Biol 24:6581–6591. doi:10.1128/MCB.24.15.6581-6591.2004 PubMedCrossRef

57.

Singh RR, Barnes CJ, Talukder AH, Fuqua SA, Kumar R (2005) Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein. Cancer Res 65:10594–10601. doi:10.1158/0008-5472.CAN-05-2268 PubMedCrossRef

58.

Mishra SK, Yang Z, Mazumdar A, Talukder AH, Larose L, Kumar R (2004) Metastatic tumor antigen 1 short form (MTA1s) associates with casein kinase I-gamma2, an estrogen-responsive kinase. Oncogene 23:4422–4429. doi:10.1038/sj.onc.1207569 PubMedCrossRef

59.

Mishra SK, Talukder AH, Gururaj AE et al (2004) Upstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway. J Biol Chem 279:32709–32715. doi:10.1074/jbc.M402942200 PubMedCrossRef

60.

Fujita N, Kajita M, Taysavang P, Wade PA (2004) Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cells. Mol Endocrinol 18:2937–2949. doi:10.1210/me.2004-0258 PubMedCrossRef

61.

Zhang H, Singh RR, Talukder AH, Kumar R (2006) Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway. Genes Dev 20:2943–2948. doi:10.1101/gad.1461706 PubMedCrossRef

62.

Gururaj AE, Singh RR, Rayala SK et al (2006) MTA1, a transcriptional activator of breast cancer amplified sequence 3. Proc Natl Acad Sci USA 103:6670–6675. doi:10.1073/pnas.0601989103 PubMedCrossRef

63.

Gururaj AE, Holm C, Landberg G, Kumar R (2006) Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer. Cell Cycle 5:1407–1410PubMed

64.

Matsusue K, Takiguchi S, Toh Y, Kono A (2001) Characterization of mouse metastasis-associated gene 2: genomic structure, nuclear localization signal, and alternative potentials as transcriptional activator and repressor. DNA Cell Biol 20:603–611. doi:10.1089/104454901753340596 PubMedCrossRef

65.

Luo J, Su F, Chen D, Shiloh A, Gu W (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408:377–381. doi:10.1038/35042612 PubMedCrossRef

66.

Moon HE, Cheon H, Lee MS (2007) Metastasis-associated protein 1 inhibits p53-induced apoptosis. Oncol Rep 18:1311–1314PubMed

67.

Yoo YG, Kong G, Lee MO (2006) Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1. EMBO J 25:1231–1241. doi:10.1038/sj.emboj.7601025 PubMedCrossRef

68.

Moon HE, Cheon H, Chun KH et al (2006) Metastasis-associated protein 1 enhances angiogenesis by stabilization of HIF-1alpha. Oncol Rep 16:929–935PubMed

69.

Yoo YG, Na TY, Seo HW et al (2008) Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 27:3405–3413. doi:10.1038/sj.onc.1211000 PubMedCrossRef

70.

Schmidt DR, Schreiber SL (1999) Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4. Biochemistry 38:14711–14717. doi:10.1021/bi991614n PubMedCrossRef

71.

Zhang XY, DeSalle LM, Patel JH et al (2005) Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proc Natl Acad Sci USA 102:13968–13973. doi:10.1073/pnas.0502330102 PubMedCrossRef

72.

Molli PR, Singh RR, Lee SW, Kumar R (2008) MTA1-mediated transcriptional repression of BRCA1 tumor suppressor gene. Oncogene 27:1971–1980. doi:10.1038/sj.onc.1210839 PubMedCrossRef

73.

Aramaki Y, Ogawa K, Toh Y et al (2005) Direct interaction between metastasis-associated protein 1 and endophilin 3. FEBS Lett 579:3731–3736. doi:10.1016/j.febslet.2005.05.069 PubMedCrossRef

74.

Nicolson GL, Nawa A, Toh Y, Taniguchi S, Nishimori K, Moustafa A (2003) Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clin Exp Metastasis 20:19–24. doi:10.1023/A:1022534217769 PubMedCrossRef

75.

Qian H, Yu J, Li Y et al (2007) RNA interference against metastasis-associated gene 1 inhibited metastasis of B16F10 melanoma cell in C57BL/6 model. Biol Cell 99:573–581. doi:10.1042/BC20060130 PubMedCrossRef

76.

Singh RR, Kaluarachchi K, Chen M et al (2006) Solution structure and antiestrogenic activity of the unique C-terminal, NR-box motif-containing region of MTA1s. J Biol Chem 281:25612–25621. doi:10.1074/jbc.M604444200 PubMedCrossRef

77.

Assudani DP, Ahmad M, Li G, Rees RC, Ali SA (2006) Immunotherapeutic potential of DISC-HSV and OX40L in cancer. Cancer Immunol Immunother 55:104–111. doi:10.1007/s00262-005-0004-y PubMedCrossRef

78.

Li G, Miles A, Line A, Rees RC (2004) Identification of tumour antigens by serological analysis of cDNA expression cloning. Cancer Immunol Immunother 53:139–143. doi:10.1007/s00262-003-0471-y PubMedCrossRef

79.

Li W, Zhang J, Liu X, Xu R, Zhang Y (2007) Correlation of appearance of metastasis-associated protein1 (Mta1) with spermatogenesis in developing mouse testis. Cell Tissue Res 329:351–362. doi:10.1007/s00441-007-0412-8 PubMedCrossRef

80.

Li W, Liu XP, Xu RJ, Zhang YQ (2007) Immunolocalization assessment of metastasis-associated protein 1 in human and mouse mature testes and its association with spermatogenesis. Asian J Androl 9:345–352. doi:10.1111/j.1745-7262.2007.00245.x PubMedCrossRef

81.

Thakur MK, Ghosh S (2008) Interaction of estrogen receptor alpha transactivation domain with MTA1 decreases in old mouse brain. J Mol Neurosci. doi:10.1007/s12031-008-9131-1

82.

Manavathi B, Peng S, Rayala SK et al (2007) Repression of Six3 by a corepressor regulates rhodopsin expression. Proc Natl Acad Sci USA 104:13128–13133. doi:10.1073/pnas.0705878104 PubMedCrossRef

83.

Li W, Zhu H, Bao W et al (2008) Involvement of metastasis tumor antigen 1 in hepatic regeneration and proliferation. Cell Physiol Biochem 22:315–326. doi:10.1159/000149810 PubMedCrossRef

84.

Chen Z, Han M (2001) Role of C. elegans lin-40 MTA in vulval fate specification and morphogenesis. Development 128:4911–4921PubMed

85.

Solari F, Ahringer J (2000) NURD-complex genes antagonise Ras-induced vulval development in Caenorhabditis elegans. Curr Biol 10:223–226. doi:10.1016/S0960-9822(00)00343-2 PubMedCrossRef

Title: The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications
Authors: Yasushi Toh
Garth L. Nicolson
Publication date: 01-03-2009
Publisher: Springer Netherlands
Published in: Clinical & Experimental Metastasis / Issue 3/2009
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI: https://doi.org/10.1007/s10585-008-9233-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2009

A gene expression signature that defines breast cancer metastases

The CXCR4/CXCL12 axis in endometrial cancer

Chitosan hydrogel containing GMCSF and a cancer drug exerts synergistic anti-tumor effects via the induction of CD8+ T cell-mediated anti-tumor immunity

Inhibition of ovarian cancer cell metastasis by a fusion polypeptide Tat-ELP

BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-κB binding site of the uPA promoter

Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung

Keynote webinar | Spotlight on antibody–drug conjugates in cancer